Company intelligence / Profile preview

SynphaTec

Idar-Oberstein, Rhineland-Palatinate, Germany

Ownership: Private
Development stage: Other

Overview

SynphaTec is a German-based contract research and manufacturing organization (CRO/CMO) specializing in the custom synthesis of complex organic molecules and pharmaceutical intermediates. The company provides essential services to the global pharmaceutical and biotechnology sectors, with particular expertise in carbohydrate chemistry, the synthesis of drug impurities, and metabolites. In addition to custom synthesis, SynphaTec offers sophisticated analytical services, including structural elucidation and the development of reference standards. Their capabilities support various stages of drug discovery and development by providing high-quality chemical building blocks and process development expertise.

Modalities: Small moleculePeptidesCarbohydrates
Industry: Drug Discovery Services

Beyond the preview

Go deeper on SynphaTec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynphaTec.

Explore the full profile